Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001576280-21-000040)

Filing Details

Accession Number:
0001576280-21-000040
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-14 18:06:14
Reporting Period:
2021-04-12
Accepted Time:
2021-04-14 18:06:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576280 Guardant Health Inc. GH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283102 J Stanley Meresman 505 Penobscot Drive
Redwood City CA 94063		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-12 4,934 $5.94 8,993 No 4 M Direct
Common Stock Disposition 2021-04-12 1,606 $151.91 7,387 No 4 S Direct
Common Stock Disposition 2021-04-12 594 $152.99 6,793 No 4 S Direct
Common Stock Disposition 2021-04-12 1,584 $154.47 5,209 No 4 S Direct
Common Stock Disposition 2021-04-12 940 $155.46 4,269 No 4 S Direct
Common Stock Disposition 2021-04-12 210 $156.59 4,059 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock STOCK OPTION (RIGHT TO BUY) Disposition 2021-04-12 4,934 $0.00 4,934 $5.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
64,143 2028-05-09 No 4 M Direct
Footnotes
  1. These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $151.71 to $152.305, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $152.76 to $153.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $154.055 to $155.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.11 to $156.015, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.12 to $156.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  7. The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018.